NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
PSIVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PSIVANT
ST13
US500000097776585Class
5, 42, 44
Filing
97776585
Registration
7583609
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/03/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
02/01/2023
Registration date
12/03/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
BOSTON, MA
Examiner
SANGID, HANA RONNY
Law office
O10
Current location
PETITIONS OFFICE
Holders and representatives
Holders
PSIVANT THERAPEUTICS, INC.
ROIVANT DISCOVERY, INC.
Roivant Sciences GmbH
Representatives
Joyce M. Ferraro FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for use in the fields of oncologyinflammationimmunology; biologic preparations for medical and therapeutic purposes for use in the fields of oncologyinflammationimmunology
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the fields of pharmaceuticals and biomedicine; analysis of technical data by computersbeing technical medical research in the field of healthcareprescription and related data being carried out using computers; pharmaceuticalbiomedicalbiological therapeutic research services; pharmaceuticalbiomedicalbiological therapeutic research services using molecular dynamics simulation to improve upon existing drugs with known deficiencies; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticalsbiomedicineclinical trials and post-market trials; cloud computing featuring software for use in database management; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticalsmedical informationclinical trial and post-market trial data for collectinganalyzing and organizing data; providing temporary use of online nondownloadable computer software for management of medical practices and research; providing temporary use of online nondownloadable computer search engine software for accessing and providing updated scientificmedical and clinical informationnews information of general interest; providing temporary use of online non-downloadable computer software for accessingcontrolling and managing data and information related to healthcare services and patient medical information; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services
Class 44
Providing health and medical information; providing internet-based healthcare information; providing medical and healthcare information to healthcare professionals regarding patient data; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions; medical services; medical and pharmaceutical consultation; medical servicesproviding medical services and consultation over the telephone and via the Internet through the use of personal computerssmartphonestabletsmobile and wireless devicesother telecommunication devices; medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
CHPB
POST PUBLICATION AMENDMENT - ENTERED
11/01/2024
APET
ASSIGNED TO PETITION STAFF
10/21/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2024
GNRT
NON-FINAL ACTION E-MAILED
05/01/2024
CNRT
NON-FINAL ACTION WRITTEN
05/01/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2024
ALIE
ASSIGNED TO LIE
02/20/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/27/2023
GNRT
NON-FINAL ACTION E-MAILED
06/27/2023
CNRT
NON-FINAL ACTION WRITTEN
06/27/2023
DOCK
ASSIGNED TO EXAMINER
05/31/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/21/2023
NWAP
NEW APPLICATION ENTERED
02/07/2023
Continuous trademark protection
Get notified about every new filing that threatens PSIVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.